Bo Lumholtz

HLA ANTIGENS IN GRAVES' DISEASE

Karine Bech, Bo Lumholtz, Jørn Nerup et al. · European Journal of Endocrinology · 1977 · 155 citations

Hla, Histocompatibility, Control Group +14

Pharmacokinetics and pharmacodynamics of NTBC (2‐(2‐nitro‐4‐fluoromethylbenzoyl)‐1,3‐cyclohexanedione) and mesotrione, inhibitors of 4‐hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers

Michael G. Hall, Martin F. Wilks, W. McLean Provan et al. · British Journal of Clinical Pharmacology · 2001 · 111 citations · Full text

Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression

I. Krog‐Meyer, C. Kirkegaard, B Kijne et al. · American Journal of Psychiatry · 1984 · 53 citations

Psychotropic Medication, Mental Health, Relapse Prevention +18

Sulfamethizole‐induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism

Bo Lumholtz, Siersbaek‐Nielsen Kaj, L. Skovsted et al. · Clinical Pharmacology & Therapeutics · 1975 · 51 citations

DRUG ELIMINATION AND RENAL FUNCTION

M. Kristensen, J. Mølholm Hansen, J. P. Kampmann et al. · The Journal of Clinical Pharmacology · 1974 · 27 citations · Full text

Renal Function, Medicine, Dialysis +3